Home Healthcare Business Broker
Sell your home healthcare agency.
Free, confidential valuation for owners of home health, private-duty home care, and hospice agencies. A Neumann & Associates represents you through the entire sale, with every buyer pre-qualified under NDA.
What buyers pay for in home healthcare.
Home healthcare is not valued on EBITDA alone. Buyers underwrite the things that make earnings durable and transferable through a change of ownership, the factors below, and agencies that score well on them command the strongest multiples.
Certification is the biggest fork in the valuation road. A Medicare-certified agency with clean surveys and transferable state licenses trades in a meaningfully higher band than a non-certified one, and in certificate-of-need states the license itself carries value.
A balanced book across Medicare, Medicaid, managed care, and private pay is the value driver an owner controls most directly. Buyers discount agencies that live on a single managed-care contract or one state Medicaid program.
Admissions sourced from a broad base of hospitals, discharge planners, physicians, and facilities are durable revenue. A referral book that survives the owner stepping away is among the first things acquirers test.
Nurses, therapists, and aides are the scarcest asset in the industry. Low clinician and caregiver turnover, credentialed supervisors, and a working recruiting engine directly de-risk the deal for a buyer.
A steady patient census, and for private-duty agencies a base of recurring weekly hours with strong client retention, turns revenue into the predictable stream buyers pay a premium for.
Strong CMS star ratings, clean survey history, and orderly clinical documentation lift the multiple, while open audits or recent deficiencies push offers down regardless of earnings.
An agency that runs on an administrator, a director of nursing, and documented systems, rather than the owner holding every referral relationship, widens the buyer pool and lifts the multiple.
Books with documented add-backs, clean claims data, and payer-level margin visibility keep offers strong and due diligence moving.
What reduces value
The same factors work in reverse. These are the issues that pull the multiple down or stall a deal:
Payer concentration, when one managed-care contract or a single Medicaid program drives most of revenue, buyers discount hard or push for earnouts.
Referral concentration, an admissions book dependent on one hospital system or one discharge planner is treated as fragile revenue.
Compliance overhang, open audits, survey deficiencies, or billing irregularities stall diligence and push offers to the low end of the range.
Clinician churn and owner dependence, chronic turnover among nurses and caregivers, or an owner who doubles as administrator and chief referral source, raises buyer risk and shrinks the buyer pool.
Reimbursement exposure, an agency positioned entirely against one payer's rate-setting decisions carries more risk than a diversified book and trades accordingly.
Most of these discounts are fixable in the 12 to 24 months before a sale. The earlier the preparation starts, the more of the multiple you keep.
Home Healthcare Businesses businesses we represent.
A Neumann & Associates represents owners across the full range of home healthcare and home-based care businesses valued at $1M and up.
What is your home healthcare business worth?
Most home healthcare agencies are valued on a multiple of earnings, and the single biggest fork in the road is Medicare certification. Non-medical private-duty and personal-care agencies are typically valued at about 3x to 5x EBITDA at the smaller end, with regional operators, especially those with private-pay-heavy books and strong recurring hours, reaching 5x to 8x. Medicare-certified skilled home health trades higher: small single-branch agencies commonly bring 3x to 6x EBITDA, regional multi-branch agencies in the $5 million to $25 million revenue range command roughly 6x to 9x, and scaled multi-state platforms trade at 9x to 12x and beyond, the tier where 2026's $1.1 billion Enhabit sale priced at 10.2x EBITDA. What moves your number within those ranges is payer mix, the breadth and transferability of your referral relationships, licensed staff retention, survey history and quality scores, census stability, and clean, verifiable billing. A confidential business valuation establishes your defensible number before you go to market.
Wondering what your home healthcare business is worth in today’s market? Start with a free, confidential valuation, no obligation.
Request a Free Consultation →A consolidating market is meeting an aging country.
The demand curve behind home healthcare is not one anyone argues with. By 2030, every baby boomer will be 65 or older, and by 2034 the Census Bureau projects 77 million Americans age 65 and up, outnumbering children for the first time in U.S. history. Three-quarters of adults over 50 say they want to age in their own homes, and the Bureau of Labor Statistics projects home health and personal care aide employment to grow 18% from 2025 to 2035, with roughly 760,500 openings a year. Care keeps moving into the home, and buyers are underwriting that shift.
The buyers are active and well capitalized. Mertz Taggart tracked 105 home-based care transactions closed in 2025, up 21 over the year before, and the pace has carried into 2026: Kinderhook Industries agreed to acquire Enhabit Home Health & Hospice for $1.1 billion at 10.2x EBITDA, Aveanna Healthcare paid $175.5 million for pediatric provider Family First Homecare, and The Pennant Group closed a $146.5 million purchase of 54 divested Amedisys and UnitedHealth locations. Public strategics like Addus HomeCare and BrightSpring Health Services, and PE-backed platforms like Help at Home, add agencies every year. For a seller, that density of well-capitalized buyers means a well-run agency, especially one with a diversified payer mix and referral base, can draw competing offers rather than a single opportunistic bid.
Who buys home healthcare businesses.
Ready to reach qualified, pre-screened buyers for your home healthcare business? Every introduction happens under NDA, never a public listing.
Request a Free Consultation →How we sell your business.
A confidential, advisor-run process built to protect your business and maximize price, the same disciplined steps on every engagement.
Confidential valuation
We establish a defensible, third-party-grade value for your business before anything goes to market, so you set the asking price from a position of knowledge.
NDA-gated marketing & CIM
We prepare a detailed Confidential Information Memorandum and take it only to pre-qualified buyers, each one under a signed non-disclosure agreement. Your business is never posted on a public listing portal.
Vetted, qualified buyers
Every buyer is financially screened before they see anything that identifies your company, so your time goes only to serious, capable acquirers.
Offers & LOI
We manage competing interest, negotiate terms, and bring you to a letter of intent that reflects the real value of the business and the right deal structure.
Due diligence
We coordinate the data room, buyer requests, and your attorney and CPA, keeping the process organized and on schedule through to the purchase agreement.
Closing
We drive the transaction to signed documents and a funded close, staying on point through the final details so the deal actually gets done.
Owners who sold with A Neumann & Associates.
“I’m delighted to offer my highest recommendation for A Neumann & Associates (particularly Gary Herviou), who played an invaluable role in helping me successfully acquire my first business. From start to finish, Gary demonstrated exceptional professionalism, expertise, and dedication that went above and beyond my expectations. Navigating the complexities of buying a business can be daunting, but Gary made the entire process seamless and stress-free.”
“With a family owned business, there are emotional ties that sometimes blur the best decisions for the business. Gary was able to handle the situation with empathy and his knowledge made what could be a tearful discussion, filled with opportunity.”
Your sale stays private, start to finish.
A Neumann & Associates runs every engagement under strict confidentiality. Your business is never listed on a public marketplace, and no buyer learns anything that identifies it until they are pre-qualified and have signed a non-disclosure agreement.
All marketing is anonymized: the Confidential Information Memorandum presents the opportunity without exposing your name, location, or customer relationships. That protects your employees, your customers, your suppliers, and your standing with competitors, so the people who keep the business running are not unsettled by a sale they hear about secondhand, and your negotiating leverage stays intact.
Thinking about selling your home healthcare business? Start with a free, confidential conversation, your name stays private until you decide to move.
Get a Free, Confidential Valuation →Home Healthcare Businesses business sale FAQ.
Who buys home healthcare agencies?
What is my home healthcare agency worth?
How long does it take to sell a home healthcare agency?
What is a typical fee for a business broker?
How do I keep the sale of my home healthcare agency confidential?
How can I avoid capital gains tax when selling my home healthcare agency?
Ready to sell your home healthcare business?
Request a free, confidential valuation with A Neumann & Associates. We’ll walk you through a realistic number and the steps to a successful sale, no obligation.